Id http://purl.obolibrary.org/obo/NCIT_C161598
http://purl.obolibrary.org/obo/NCIT_C161598
Preferred Name

Multi-kinase Inhibitor XL092

Definitions
An orally bioavailable, receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Upon oral administration, multi-kinase inhibitor XL092 strongly binds to and inhibits several RTKs that are often overexpressed in a variety of cancer cell types, including hepatocyte growth factor receptor (proto-oncogene c-Met) and certain vascular endothelial growth factor receptor (VEGFR) subtypes. This may result in an inhibition of both tumor growth and angiogenesis, and eventually lead to tumor regression.
Type http://www.w3.org/2002/07/owl#Class
Delete Subject Author Type Created
No notes to display